BACKGROUND: Physical activity has many health benefits. Although greater activity has been related to lower postmenopausal breast cancer risk, important details remain unclear, including type, intensity, and timing of activity and whether the association varies by subgroups. METHODS: Within the prospective Nurses' Health Study, we assessed the associations of specific and total activity, queried every 2 to 4 years since 1986, with breast cancer risk. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Activity was measured as hours of metabolic equivalent task values (MET-h). RESULTS: During 20 years of follow-up (1986-2006), 4782 invasive breast cancer cases were documented among 95 396 postmenopausal women. Compared with less than 3 MET-h/wk (<1 h/wk walking), women engaged in higher amounts of recent total physical activity were at lower breast cancer risk (≥27 MET-h/wk [approximately 1 h/d of brisk walking]: HR, 0.85; 95% CI, 0.78-0.93; P < .001 for trend). Compared with women who were least active at menopause and through follow-up (<9 MET-h/wk [approximately 30 minutes of walking at an average pace on most days of the week]), women who increased activity were at lower risk (<9 MET-h/wk at menopause and ≥9 MET-h/wk during follow-up: HR, 0.90; 95% CI, 0.82-0.98). Among specific activities modeled simultaneously, brisk walking was associated with lower risk (per 20 MET-h/wk [5 h/wk]: HR, 0.91; 95% CI, 0.84-0.98). The association with total activity did not differ significantly between estrogen and progesterone receptor-positive and -negative tumors (P = .65 for heterogeneity). CONCLUSION: Our findings suggest that moderate physical activity, including brisk walking, may reduce postmenopausal breast cancer risk and that increases in activity after menopause may be beneficial.
BACKGROUND: Physical activity has many health benefits. Although greater activity has been related to lower postmenopausal breast cancer risk, important details remain unclear, including type, intensity, and timing of activity and whether the association varies by subgroups. METHODS: Within the prospective Nurses' Health Study, we assessed the associations of specific and total activity, queried every 2 to 4 years since 1986, with breast cancer risk. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Activity was measured as hours of metabolic equivalent task values (MET-h). RESULTS: During 20 years of follow-up (1986-2006), 4782 invasive breast cancer cases were documented among 95 396 postmenopausal women. Compared with less than 3 MET-h/wk (<1 h/wk walking), women engaged in higher amounts of recent total physical activity were at lower breast cancer risk (≥27 MET-h/wk [approximately 1 h/d of brisk walking]: HR, 0.85; 95% CI, 0.78-0.93; P < .001 for trend). Compared with women who were least active at menopause and through follow-up (<9 MET-h/wk [approximately 30 minutes of walking at an average pace on most days of the week]), women who increased activity were at lower risk (<9 MET-h/wk at menopause and ≥9 MET-h/wk during follow-up: HR, 0.90; 95% CI, 0.82-0.98). Among specific activities modeled simultaneously, brisk walking was associated with lower risk (per 20 MET-h/wk [5 h/wk]: HR, 0.91; 95% CI, 0.84-0.98). The association with total activity did not differ significantly between estrogen and progesterone receptor-positive and -negative tumors (P = .65 for heterogeneity). CONCLUSION: Our findings suggest that moderate physical activity, including brisk walking, may reduce postmenopausal breast cancer risk and that increases in activity after menopause may be beneficial.
Authors: Anne McTiernan; Shelley S Tworoger; Cornelia M Ulrich; Yutaka Yasui; Melinda L Irwin; Kumar B Rajan; Bess Sorensen; Rebecca E Rudolph; Deborah Bowen; Frank Z Stanczyk; John D Potter; Robert S Schwartz Journal: Cancer Res Date: 2004-04-15 Impact factor: 12.701
Authors: T Moradi; H O Adami; R Bergström; G Gridley; A Wolk; M Gerhardsson; M Dosemeci; O Nyrén Journal: Cancer Causes Control Date: 1999-10 Impact factor: 2.506
Authors: B E Ainsworth; W L Haskell; A S Leon; D R Jacobs; H J Montoye; J F Sallis; R S Paffenbarger Journal: Med Sci Sports Exerc Date: 1993-01 Impact factor: 5.411
Authors: J E Manson; F B Hu; J W Rich-Edwards; G A Colditz; M J Stampfer; W C Willett; F E Speizer; C H Hennekens Journal: N Engl J Med Date: 1999-08-26 Impact factor: 91.245
Authors: Anne McTiernan; Charles Kooperberg; Emily White; Sara Wilcox; Ralph Coates; Lucile L Adams-Campbell; Nancy Woods; Judith Ockene Journal: JAMA Date: 2003-09-10 Impact factor: 56.272
Authors: G A Colditz; M J Stampfer; W C Willett; W B Stason; B Rosner; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1987-08 Impact factor: 4.897
Authors: A M Wolf; D J Hunter; G A Colditz; J E Manson; M J Stampfer; K A Corsano; B Rosner; A Kriska; W C Willett Journal: Int J Epidemiol Date: 1994-10 Impact factor: 7.196
Authors: Mengmeng Du; Jennifer Prescott; Peter Kraft; Jiali Han; Edward Giovannucci; Susan E Hankinson; Immaculata De Vivo Journal: Am J Epidemiol Date: 2012-02-01 Impact factor: 4.897
Authors: Caroline E Boeke; A Heather Eliassen; Hannah Oh; Donna Spiegelman; Walter C Willett; Rulla M Tamimi Journal: Breast Cancer Res Treat Date: 2014-03-30 Impact factor: 4.872
Authors: Michael Gleeson; Nicolette C Bishop; David J Stensel; Martin R Lindley; Sarabjit S Mastana; Myra A Nimmo Journal: Nat Rev Immunol Date: 2011-08-05 Impact factor: 53.106
Authors: Megan S Rice; Shelley S Tworoger; Susan E Hankinson; Rulla M Tamimi; A Heather Eliassen; Walter C Willett; Graham Colditz; Bernard Rosner Journal: Breast Cancer Res Treat Date: 2017-07-12 Impact factor: 4.872
Authors: Stephanie R Land; Qing Liu; D Lawrence Wickerham; Joseph P Costantino; Patricia A Ganz Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-02-25 Impact factor: 4.254
Authors: Mengmeng Du; Peter Kraft; A Heather Eliassen; Edward Giovannucci; Susan E Hankinson; Immaculata De Vivo Journal: Int J Cancer Date: 2013-11-29 Impact factor: 7.396
Authors: Adana A M Llanos; Jessica L Krok; Juan Peng; Michael L Pennell; Mara Z Vitolins; Cecilia R Degraffinreid; Electra D Paskett Journal: Horm Cancer Date: 2014-01-17 Impact factor: 3.869